ArticleBMC women's health2025
Sexual dysfunction in women with genital warts: a cross-sectional study.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epidemiology of Human Papillomavirus in the Middle East and North Africa: A Review of Genotypic Prevalence, Vaccination Challenges, and Non-Cervical Clinical Outcomes.Diseases (Basel, Switzerland) · 2026Review
- The impact of human papillomavirus positivity and genotype on sexual dysfunction and psychosexual stress.Turkish journal of obstetrics and gynecology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate sexual dysfunction and quality of life in women with genital warts.
methodsA total of 100 women were included if they were aged 18-45 years, had genital warts (GWs) for at least three months, and were in a stable marital relationship for at least six months. All participants completed the Female Sexual Function Index (FSFI) and the Dermatology Life Quality Index (DLQI) questionnaires.
resultsShowed that the lowest mean scores were observed in the domains of orgasm (1.91 ± 1.07), arousal (2.82 ± 1.12), satisfaction (3.01 ± 1.01), pain (3.11 ± 1.34), desire (3.37 ± 1.01), and lubrication (3.64 ± 1.32). Total FSFI score was 17.64 ± 6.15. The presence of GWs had a significant very large impact on patients QOL in 49% of participants (p < 0.001).
conclusionsResults demonstrated sexual and quality of life affection among females complaining of genital warts. Sexual health and dysfunction should be routinely assessed in women presenting with genital warts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.